Determinants of health-related quality of life in anti-MAG neuropathy: a cross-sectional multicentre European study

Keyphrases

• Anger 20%
• Ataxia Score 40%
• Birmingham UK 20%
• Clinical Evaluation 20%
• Determinants of Health 100%
• Determinants of Quality of Life 20%
• Disability Evaluation 80%
• Dynamometry 40%
• Effective Metric 20%
• European Studies 100%
• Fatigue Management 20%
• Fatigue Severity Scale 100%
• France 20%
• Health-related Quality of Life 100%
• Inflammatory Neuropathy 20%
• Marseille 20%
• Medical Research Council 40%
• Mental Component Summary 80%
• Multivariate Regression 20%
• Myelin Oligodendrocyte Glycoprotein Antibody 100%
• Neuropathic Pain Management 20%
• Neuropathic Pain Symptom Inventory 60%
• Neuropathy 100%
• Pain Score 40%
• Physical Component Summary 60%
• Quality of Life 40%
• Rasch 80%
• Sensory Score 20%
• Severity Level 40%
• SF-36 Questionnaire 40%
• Short Form 36 (SF-36) 20%
• Social Support 60%
• Treatment Fatigue 20%
• Tremor 40%

Medicine and Dentistry

• Ataxia 50%
• Clinical Trial 25%
• Determinants of Health 100%
• Dynamometry 50%
• Medical Research 50%
• Myelin Associated Glycoprotein 100%
• Neuropathic Pain 100%
• Neuropathy 100%
• Pain (Symptom) 75%
• Quality of Life 100%
• Short Form 36 75%
• Social Support 75%

Neuroscience

• Ataxia 50%
• Myelin Associated Glycoprotein 100%
• Neuropathic Pain 100%
• Neuropathy 100%
• Tremor 50%